Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Viruses|August 28, 2025
Hemophagocytic Lymphohistiocytosis Gene Variants in Severe COVID-19 Cytokine Storm SyndromeAbhishek Kamath, Mingce Zhang, Devin M Absher, et al.
Current Rheumatology Reports|August 4, 2014
Genetic defects in cytolysis in macrophage activation syndromeMingce Zhang, Edward M Behrens, T Prescott Atkinson, et al.
Pediatric Rheumatology Online Journal|February 13, 2020
Adolescent Sjogren's syndrome presenting as psychosis: a case seriesErin K Hammett, Cristina Fernandez-Carbonell, Courtney Crayne, et al.
ACR Open Rheumatology|November 29, 2019
Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic ArthritisEsraa M A Eloseily, Francesca Minoia, Courtney B Crayne, et al.
Clinical Immunology (Orlando, Fla.)|January 22, 2023
Interrelation of T cell cytokines and autoantibodies in systemic lupus erythematosus: A cross-sectional studyFatima K Alduraibi, Kathryn A Sullivan, W Winn Chatham, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 23, 2020
Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension StudyW Winn Chatham, Richard Furie, Amit Saxena, et al.
Arthritis Care & Research|October 10, 2013
Imaging of the temporomandibular joint in juvenile idiopathic arthritisYoginder N Vaid, F Daniel Dunnavant, Stuart A Royal, et al.
The Journal of Rheumatology|February 3, 2011
An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritisSergio Davì, Alessandro Consolaro, Dinara Guseinova, et al.
The Journal of Rheumatology|March 3, 2010
Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimensMara L Becker, Carlos D Rosé, Randy Q Cron, et al.
Pageof 19